Managing HIV-associated inflammation and ageing in the era of modern ART.

HIV Medicine
M BlochEdwina Wright

Abstract

This paper aims to address the concerns around ongoing immune activation, inflammation, and resistance in those ageing with HIV that represent current challenges for clinicians. Presentations at a symposium addressing issues of ageing with HIV infection were reviewed and synthesised. The changing natural history and demographics of human immunodeficiency virus (HIV)-infected individuals means new challenges in contemporary management. In the early years of the epidemic,management was focussed on acute, potentially life-threatening AIDS-related complications. From initial monotherapy with first-generation antiretroviral therapy (ART), the development of combination highly active ART (HAART) allowed HIV control but ART toxicities, treatment adherence and drug resistance emerged as major issues. Today, the availability of potent and tolerable ART has made viral suppression achievable in most people living with HIV (PLHIV), and clinicians are confronted with managing a chronic condition among an ageing population. The combination of diseases of ageing and the co-morbidities associated with HIV-infection, even when well controlled, results in a complex set of challenges for many older PLHIV. There is a growing appreciation that many...Continue Reading

References

Oct 1, 1996·Annals of Internal Medicine·T R Fleming, D L DeMets
Jul 30, 1999·Biochemical and Biophysical Research Communications·P D PeltonT P Burris
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L P FriedUNKNOWN Cardiovascular Health Study Collaborative Research Group
Dec 18, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A AmmassariUNKNOWN AdICONA Study Group
Mar 20, 2003·Journal of the American College of Cardiology·Prediman K Shah
Dec 16, 2003·The Journal of Infectious Diseases·Howard M LedermanUNKNOWN AIDS Clinical Trials Group 889 Study Team
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric A EngelsRichard D Moore
Jun 8, 2006·Age and Ageing·Darryl B RolfsonKenneth Rockwood
Nov 23, 2006·Nature Medicine·Jason M BrenchleyDaniel C Douek
Dec 1, 2006·Arthritis and Rheumatism·Daniel H SolomonSebastian Schneeweiss
Jan 18, 2007·Annals of Internal Medicine·Nicolai LohseNiels Obel
Feb 12, 2008·The Journal of Infectious Diseases·Tae-Wook ChunAnthony S Fauci
Mar 8, 2008·Arthritis Research & Therapy·Antonio NaranjoUNKNOWN QUEST-RA Group
Apr 23, 2008·AIDS·Jason V BakerUNKNOWN Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
Jul 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rita B EffrosKevin P High
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
Apr 24, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Virginia A TriantSteven K Grinspoon
Dec 10, 2009·AIDS·Samanta SimioniRenaud A Du Pasquier
Jan 6, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Christian ErikstrupHenrik Ullum
May 8, 2010·The Journal of Infectious Diseases·Jacqueline NeuhausJames D Neaton
Jun 29, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Phyllis C TienCarl Grunfeld
Aug 12, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amanda MocroftUNKNOWN EuroSIDA Study Group
Oct 5, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shari N GordonGuido Silvestri
Nov 26, 2010·Annual Review of Medicine·Steven G Deeks
Nov 26, 2010·Clinics in Geriatric Medicine·Kenneth Rockwood, Arnold Mitnitski
Jan 22, 2011·The Journal of Infectious Diseases·Netanya G SandlerUNKNOWN INSIGHT SMART Study Group
Apr 9, 2011·Biomarkers in Medicine·Gregor F LichtfussSharon R Lewin
Jul 2, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Loic DesquilbetJoseph B Margolick
Mar 1, 2012·Current Pharmaceutical Design·Alexios S AntonopoulosCharalambos Antoniades

❮ Previous
Next ❯

Citations

Jan 16, 2021·ELife·Daniel Sauter, Frank Kirchhoff
Feb 14, 2021·Environmental Toxicology and Pharmacology·Lucia RackovaZuzana Brnoliakova
Mar 2, 2021·Frontiers in Immunology·Berend J van WelzenAndy I M Hoepelman
May 24, 2021·Drug Discovery Today·Zeenat A ShyrWei Zheng
Oct 2, 2021·Journal of Cachexia, Sarcopenia and Muscle·Matteo BonatoPaola Cinque

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.